This is a renewal of an Established Investigator award for Dr. Polly Newcomb to dedicate 30% effort to training and research in colorectal cancer survivorship. She is an experienced cancer prevention and control investigator with a long and successful record of continuous NIH-funding, with nearly $40 M in direct awards to her as Principal Investigator. An effective mentor, she has worked with over 40 young scientists on their way to independent careers in cancer prevention and control. This K05 has allowed her to focus her career on the epidemiology and genetics of colon cancer survival. With support of the K05 she has obtained additional skills, had 4 R01 proposals funded as PI, and worked with 24 outstanding junior investigators to author ~70 study reports focused on cancer survivorship. The epidemiology of cancer survival continues to be an essential area, as the population of cancer survivors is rapidly growing because of screening and treatment successes; today more than 14 million U.S. individuals have a history of cancer. Therefore, identifying approaches to improve survival in colorectal cancer patients is a high priority for patients, clinicians, and caregivers. Colorectal cancer is a complex disease caused by the joint action of environmental, behavioral, and genetic factors; longevity after diagnosis too must reflect these joint effects. The research goals of this K05 awards are to: 1) Further develop and actively participate in the newly emerging International Survival Analysis of Colorectal Cancer Consortium (ISACC) that currently includes 23 studies and nearly 27,000 colorectal cancers, in order to initiate research projects with Consortium investigators and mentees to leverage the diverse and well-annotated populations and biospecimens collected by the participating studies; 2) Test whether the colon tumor genome, as defined by BRAF mutation, KRAS mutation, CpG Island Methylator Phenotype (CIMP), and microsatellite instability (MSI) status, is associated with colorectal cancer survival, and assess whether this association is modified by epidemiologic factors or common germline genetic variants; and 3) Develop and validate a prognostic model for survival utilizing the tumor genome, epidemiologic factors, and germline genetic variants. Cancer survivorship is a challenging area of prevention research with unique methods for analyses and controlling bias, making mentorship of junior investigators key to the successful production of significant and impactful research results. There is an outstanding pool of pre- and post-doctoral trainees from the University of Washington, with mentee funding available from 4 training grants with which Dr. Newcomb serves as a mentor and/or on the Executive Committee. Dr. Newcomb regularly meets with trainees individually, and weekly as a group, to develop expertise in study conduct, analyses, manuscript preparation, grant writing, and the responsible conduct of research. The renewal of the K05 award will be an invaluable mechanism to better understand the factors that can enhance cancer survival, and in doing so, develop junior researchers highly skilled in cancer control.
The population of cancer survivors is rapidly growing because of screening and treatment successes; today more than 14 million U.S. individuals have a history of cancer. This project will develop new research resources and support the training of a new generation of investigators focused on enhancing our understanding of factors contributing to colorectal cancer survival.
|Dienstmann, R; Mason, M J; Sinicrope, F A et al. (2017) Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study. Ann Oncol :|
|Hardikar, Sheetal; Burnett-Hartman, Andrea N; Chubak, Jessica et al. (2017) Reproductive factors and risk of colorectal polyps in a colonoscopy-based study in western Washington State. Cancer Causes Control 28:241-246|
|Veal, Christopher Thomas; Hart, Vicki; Lakoski, Susan G et al. (2017) Health-related behaviors and mortality outcomes in women diagnosed with ductal carcinoma in situ. J Cancer Surviv 11:320-328|
|Phipps, Amanda I; Robinson, Jamaica R; Campbell, Peter T et al. (2017) Prediagnostic alcohol consumption and colorectal cancer survival: The Colon Cancer Family Registry. Cancer 123:1035-1043|
|Win, Aung Ko; Jenkins, Mark A; Dowty, James G et al. (2017) Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer. Cancer Epidemiol Biomarkers Prev 26:404-412|
|Kocarnik, Jonathan M; Hua, Xinwei; Hardikar, Sheetal et al. (2017) Long-term weight loss after colorectal cancer diagnosis is associated with lower survival: The Colon Cancer Family Registry. Cancer 123:4701-4708|
|Dienstmann, R; Mason, M J; Sinicrope, F A et al. (2017) Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study. Ann Oncol 28:1023-1031|
|Robinson, Jamaica R; Newcomb, Polly A; Hardikar, Sheetal et al. (2017) Stage IV colorectal cancer primary site and patterns of distant metastasis. Cancer Epidemiol 48:92-95|
|Wang, Hansong; Schmit, Stephanie L; Haiman, Christopher A et al. (2017) Novel colon cancer susceptibility variants identified from a genome-wide association study in African Americans. Int J Cancer 140:2728-2733|
|Kocarnik, Jonathan M; Chan, Andrew T; Slattery, Martha L et al. (2016) Relationship of prediagnostic body mass index with survival after colorectal cancer: Stage-specific associations. Int J Cancer 139:1065-72|
Showing the most recent 10 out of 105 publications